Three-year follow-up of a randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine (the TREAT study)
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2016
|
| In: |
Journal of thoracic oncology
Year: 2016, Jahrgang: 11, Heft: 1, Pages: 85-93 |
| ISSN: | 1556-1380 |
| DOI: | 10.1016/j.jtho.2015.09.014 |
| Online-Zugang: | Resolving-System, Volltext: https://doi.org/10.1016/j.jtho.2015.09.014
|
| Verfasserangaben: | Michael Kreuter MD, Johan Vansteenkiste MD, Jürgen R. Fischer MD, Wilfried E. Eberhardt MD, Heike Zabeck MD, Jens Kollmeier MD, Monika Serke MD, Norbert Frickhofen MD, Martin Reck MD, Walburga Engel-Riedel MD, Silke Neumann MD, Michiel Thomeer MD, Christian Schumann MD, Paul De Leyn MD, Thomas Graeter MD, Georgios Stamatis MD, Frank Griesinger MD, Michael Thomas MD, on behalf of the TREAT investigators |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1664609253 | ||
| 003 | DE-627 | ||
| 005 | 20221207105340.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190506s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jtho.2015.09.014 |2 doi | |
| 035 | |a (DE-627)1664609253 | ||
| 035 | |a (DE-599)KXP1664609253 | ||
| 035 | |a (OCoLC)1341212331 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kreuter, Michael |d 1972- |e VerfasserIn |0 (DE-588)122645995 |0 (DE-627)082066795 |0 (DE-576)293362742 |4 aut | |
| 245 | 1 | 0 | |a Three-year follow-up of a randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine (the TREAT study) |c Michael Kreuter MD, Johan Vansteenkiste MD, Jürgen R. Fischer MD, Wilfried E. Eberhardt MD, Heike Zabeck MD, Jens Kollmeier MD, Monika Serke MD, Norbert Frickhofen MD, Martin Reck MD, Walburga Engel-Riedel MD, Silke Neumann MD, Michiel Thomeer MD, Christian Schumann MD, Paul De Leyn MD, Thomas Graeter MD, Georgios Stamatis MD, Frank Griesinger MD, Michael Thomas MD, on behalf of the TREAT investigators |
| 264 | 1 | |c 2016 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 700 | 1 | |a Vansteenkiste, Johan F. |e VerfasserIn |0 (DE-588)1156345960 |0 (DE-627)1019126175 |0 (DE-576)502120894 |4 aut | |
| 700 | 1 | |a Fischer, Jürgen |d 1953- |e VerfasserIn |0 (DE-588)133724484 |0 (DE-627)691747725 |0 (DE-576)300052510 |4 aut | |
| 700 | 1 | |a Eberhardt, Wilfried E. E. |e VerfasserIn |0 (DE-588)1058450573 |0 (DE-627)796897654 |0 (DE-576)414636554 |4 aut | |
| 700 | 1 | |a Zabeck, Heike |d 1971- |e VerfasserIn |0 (DE-588)122800982 |0 (DE-627)706049551 |0 (DE-576)293426457 |4 aut | |
| 700 | 1 | |a Kollmeier, Jens |d 1967- |e VerfasserIn |0 (DE-588)17285069X |0 (DE-627)697780031 |0 (DE-576)133706346 |4 aut | |
| 700 | 1 | |a Serke, Monika |e VerfasserIn |4 aut | |
| 700 | 1 | |a Frickhofen, Norbert |d 1954- |e VerfasserIn |0 (DE-588)1145666302 |0 (DE-627)1006855084 |0 (DE-576)16713535X |4 aut | |
| 700 | 1 | |a Reck, Martin |d 1965- |e VerfasserIn |0 (DE-588)137678711 |0 (DE-627)594837413 |0 (DE-576)30483873X |4 aut | |
| 700 | 1 | |a Engel-Riedel, Walburga |e VerfasserIn |0 (DE-588)1157290108 |0 (DE-627)1021072729 |0 (DE-576)50280825X |4 aut | |
| 700 | 1 | |a Neumann, Silke |e VerfasserIn |0 (DE-588)1194981127 |0 (DE-627)1677173378 |4 aut | |
| 700 | 1 | |a Thomeer, Michiel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schumann, Christian |d 1972- |e VerfasserIn |0 (DE-588)129158933 |0 (DE-627)390026700 |0 (DE-576)338246959 |4 aut | |
| 700 | 1 | |a DeLeyn, Paul |e VerfasserIn |0 (DE-627)1243549548 |0 (DE-576)173549543 |4 aut | |
| 700 | 1 | |a Graeter, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stamatis, Georgios |e VerfasserIn |0 (DE-588)120888221X |0 (DE-627)169584565X |4 aut | |
| 700 | 1 | |a Griesinger, Frank |e VerfasserIn |0 (DE-588)1080408916 |0 (DE-627)844436305 |0 (DE-576)453541747 |4 aut | |
| 700 | 1 | |a Thomas, Michael |e VerfasserIn |0 (DE-588)1054438781 |0 (DE-627)79152213X |0 (DE-576)41027089X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of thoracic oncology |d Amsterdam : Elsevier, 2006 |g 11(2016), 1, Seite 85-93 |h Online-Ressource |w (DE-627)508331986 |w (DE-600)2223437-8 |w (DE-576)336961553 |x 1556-1380 |7 nnas |a Three-year follow-up of a randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine (the TREAT study) |
| 773 | 1 | 8 | |g volume:11 |g year:2016 |g number:1 |g pages:85-93 |g extent:9 |a Three-year follow-up of a randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine (the TREAT study) |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jtho.2015.09.014 |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200310 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1054438781 |a Thomas, Michael |m 1054438781:Thomas, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PT1054438781 |e 950000PT1054438781 |e 950900PT1054438781 |e 50000PT1054438781 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 18 |y j | ||
| 998 | |g 122800982 |a Zabeck, Heike |m 122800982:Zabeck, Heike |d 910000 |d 950000 |d 950900 |e 910000PZ122800982 |e 950000PZ122800982 |e 950900PZ122800982 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 5 | ||
| 998 | |g 122645995 |a Kreuter, Michael |m 122645995:Kreuter, Michael |d 910000 |d 950000 |d 950900 |e 910000PK122645995 |e 950000PK122645995 |e 950900PK122645995 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 1 |x j | ||
| 999 | |a KXP-PPN1664609253 |e 3605533477 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Michael","family":"Kreuter","role":"aut","display":"Kreuter, Michael"},{"role":"aut","display":"Vansteenkiste, Johan F.","family":"Vansteenkiste","given":"Johan F."},{"given":"Jürgen","display":"Fischer, Jürgen","role":"aut","family":"Fischer"},{"family":"Eberhardt","role":"aut","display":"Eberhardt, Wilfried E. E.","given":"Wilfried E. E."},{"given":"Heike","role":"aut","display":"Zabeck, Heike","family":"Zabeck"},{"role":"aut","display":"Kollmeier, Jens","family":"Kollmeier","given":"Jens"},{"family":"Serke","display":"Serke, Monika","role":"aut","given":"Monika"},{"role":"aut","display":"Frickhofen, Norbert","family":"Frickhofen","given":"Norbert"},{"role":"aut","display":"Reck, Martin","family":"Reck","given":"Martin"},{"role":"aut","display":"Engel-Riedel, Walburga","family":"Engel-Riedel","given":"Walburga"},{"given":"Silke","display":"Neumann, Silke","role":"aut","family":"Neumann"},{"family":"Thomeer","role":"aut","display":"Thomeer, Michiel","given":"Michiel"},{"family":"Schumann","role":"aut","display":"Schumann, Christian","given":"Christian"},{"given":"Paul","role":"aut","display":"DeLeyn, Paul","family":"DeLeyn"},{"role":"aut","display":"Graeter, Thomas","family":"Graeter","given":"Thomas"},{"family":"Stamatis","display":"Stamatis, Georgios","role":"aut","given":"Georgios"},{"given":"Frank","family":"Griesinger","display":"Griesinger, Frank","role":"aut"},{"given":"Michael","display":"Thomas, Michael","role":"aut","family":"Thomas"}],"id":{"doi":["10.1016/j.jtho.2015.09.014"],"eki":["1664609253"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"2016"}],"name":{"displayForm":["Michael Kreuter MD, Johan Vansteenkiste MD, Jürgen R. Fischer MD, Wilfried E. Eberhardt MD, Heike Zabeck MD, Jens Kollmeier MD, Monika Serke MD, Norbert Frickhofen MD, Martin Reck MD, Walburga Engel-Riedel MD, Silke Neumann MD, Michiel Thomeer MD, Christian Schumann MD, Paul De Leyn MD, Thomas Graeter MD, Georgios Stamatis MD, Frank Griesinger MD, Michael Thomas MD, on behalf of the TREAT investigators"]},"title":[{"title":"Three-year follow-up of a randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine (the TREAT study)","title_sort":"Three-year follow-up of a randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine (the TREAT study)"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"pubHistory":["1.2006 -"],"language":["eng"],"disp":"Three-year follow-up of a randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine (the TREAT study)Journal of thoracic oncology","title":[{"subtitle":"JTO ; official publication of the International Association for the Study of Lung Cancer","title_sort":"Journal of thoracic oncology","title":"Journal of thoracic oncology"}],"id":{"zdb":["2223437-8"],"issn":["1556-1380"],"eki":["508331986"]},"part":{"pages":"85-93","text":"11(2016), 1, Seite 85-93","year":"2016","volume":"11","extent":"9","issue":"1"},"origin":[{"dateIssuedDisp":"2006-","publisher":"Elsevier ; Lippincott Williams & Wilkins","publisherPlace":"Amsterdam ; Philadelphia, Pa.","dateIssuedKey":"2006"}],"recId":"508331986","physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"JTO"}]}],"recId":"1664609253","physDesc":[{"extent":"9 S."}],"language":["eng"]} | ||
| SRT | |a KREUTERMICTHREEYEARF2016 | ||